Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment
about
Macroscopic thrombus formation on angioplasty equipment following antithrombin therapy with enoxaparinLow-molecular-weight heparins : mechanisms, trials, and role in contemporary interventional medicine.Use of anticoagulants in ST-segment elevation myocardial infarction patients; a focus on low-molecular-weight heparin.Catheter thrombosis and percutaneous coronary intervention: fundamental perspectives on blood, artificial surfaces and antithrombotic drugs.Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013.A novel enoxaparin regime for ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: a WEST sub-study.Recombinant nematode anticoagulant protein c2 in non-ST segment elevation acute coronary syndrome and beyond.A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generation.Primary percutaneous coronary intervention for ST-elevation myocardial infarction using an intravenous and subcutaneous enoxaparin low molecular weight heparin regimen.Unfractionated heparin during elective PCI: fixed dose or weight adjusted?Anticoagulation after subcutaneous enoxaparin is time sensitive in STEMI patients treated with tenecteplase.
P2860
Q28218235-15995ECB-5EAE-418E-9F61-BF26AE908069Q33378783-A3E06A78-7DE4-4262-AD51-681BDCF1E026Q37047875-343B2AE3-C98F-4356-8722-664309212BABQ37550053-9E649426-99F7-4D54-AAD3-E4916D27FB1BQ38106501-907728CA-80E3-4D06-A718-EC3302343D67Q39786426-38F7CF99-6942-44A4-9826-FE7A989B769DQ40199253-7F0E36A2-D1D5-4377-86EA-345D6B67AB16Q45959804-CBC79D7C-104F-456F-9992-E12A2768E5DBQ46477007-E8AE9F2D-E1DB-478A-A053-EC44AD5C4AABQ47409928-4C6AA238-3024-4D63-85C3-38273D9283E9Q53656617-80319D41-6606-4C6F-A891-BC4992CCD42F
P2860
Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@ast
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@en
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@nl
type
label
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@ast
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@en
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@nl
prefLabel
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@ast
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@en
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@nl
P2093
P2860
P921
P1476
Catheter thrombosis during pri ...... rel and abciximab pretreatment
@en
P2093
Blair J O'Neill
Christopher E Buller
Gordon E Pate
John G Webb
Paul W Armstrong
Richard Gallo
P2860
P304
P356
10.1016/S0828-282X(06)70271-9
P407
P50
P577
2006-05-01T00:00:00Z